| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83745-405-32 | 83745-405 | HUMAN PRESCRIPTION DRUG | Lactulose | Lactulose | SOLUTION | ORAL | 20241220 | N/A | ANDA | ANDA207786 | APOZEAL PHARMACEUTICALS INC | LACTULOSE | 10 g/15mL | 946 mL in 1 BOTTLE (83745-405-32) |
| 83745-405-16 | 83745-405 | HUMAN PRESCRIPTION DRUG | Lactulose | Lactulose | SOLUTION | ORAL | 20241220 | N/A | ANDA | ANDA207786 | APOZEAL PHARMACEUTICALS INC | LACTULOSE | 10 g/15mL | 473 mL in 1 BOTTLE (83745-405-16) |
| 83745-405-08 | 83745-405 | HUMAN PRESCRIPTION DRUG | Lactulose | Lactulose | SOLUTION | ORAL | 20241220 | N/A | ANDA | ANDA207786 | APOZEAL PHARMACEUTICALS INC | LACTULOSE | 10 g/15mL | 237 mL in 1 BOTTLE (83745-405-08) |